Hjem › Brystkreft › New Jersey › Clifton
Kliniske studier for Brystkreft i Clifton, NJ
12 studier for Brystkreft søker deltakere på steder i og rundt Clifton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruttererFase 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RekruttererFase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 7 mi unna
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 7 mi unna
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- John Theurer Ctr-Hackensack UMC, Hackensack · 7 mi unna
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RekruttererFase 2
- Hackensack Meridian Health, Hackensack · 7 mi unna
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi unna
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Hackensack University Medical Center, Hackensack · 7 mi unna
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi unna
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruttererObservasjonsstudie
- John Theurer Cancer Center, Hackensack · 7 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Clifton
- Ikke-småcellet lungekreft24 studier
- Kreft (alle typer)15 studier
- Multipelt myelom14 studier
- Metastatisk kreft12 studier
- Akut myelogen leukemi12 studier
- Prostatakreft12 studier
- Eggstokkreft11 studier
- Lungekreft10 studier
- Kolorektal kreft8 studier
- Plateepitelcancer i hode og hals8 studier
- Endometriekreft8 studier
- Hjertesvikt8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.